There are no Focus articles on ATTBF.
There are no Transcripts on ATTBF.
We currently have no Breaking News on this stock.
ATTBF vs. ETF Alternatives
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
Other News & PR